[Combined study of Silentan. Test of a headache remedy in general and clinical practice].
D000328:Adult; D001241:Aspirin / Q000008:administration & dosage* / Q000627:therapeutic use; D002110:Caffeine / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000008:administration & dosage* / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000627:therapeutic use; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D004338:Drug Combinations; D002110:Caffeine; D004087:Dihydroergotamine; D003975:Diazepam; D001241:Aspirin
Verbundstudie Silentan. Prüfung eines Kopfschmerzmittels in Klinik und Praxis.